A recent study has revealed a racial disparity in prostate cancer treatment of patients in the U.S.

The study, conducted in 2007 and reported in the Journal of Urology earlier this year, was led by Dr. Kathryn E. Richert-Boe, of Kaiser Permanente Northwest in Portland, Oregon. It's objectives were to determine whether differences existed in prostate cancer treatment received by white and African American men at a health maintenance organization where access to medical care (was) theoretically equal for all members and, if so, to determine the reasons for these differences.

A new study published in the September 2008 issue of CANCER from the American Cancer Society, has determined that as many as 69% of men receiving hormone deprivation therapy, a widely used treatment for patients with advanced prostate cancer, may experience detrimental effects to their cognitive abilities. According to Dr. Christian Nelson, there is strong evidence that hormone deprivation therapy is linked to "subtle but significant cognitive decline in men with prostate cancer".

In July, 2008, British researchers claimed to have won a major victory for prostate cancer treatment. According to recently release reports, a new drug, abiraterone, may be used to treat as many as 80% of patients suffering from advanced forms of prostate cancer.

Researchers worldwide involved in the treatment of prostate cancer are cautiously optimistic, and welcoming what may arguably be the best news in prostate cancer treatment research in the past 15 years.

There is one fact regarding prostate cancer treatment that a majority of doctor's who treat patients with prostate cancer all agree upon. Early detection of the disease can offer a patient's best chance for effective treatment and cure. One of the reasons that prostate cancer claims so many victims is that all too often, the disease is detected only after it has reached advanced stages.

Pancreatic cancer begins in the tissues of your pancreas, a large organ that lies horizontally behind the lower part of the stomach. Pancreatic cancer occurs most commonly in men between the ages of 35 and 70, it is the fourth most common cause of cancer mortality (behind lung cancer, colorectal cancer and breast cancer). Pancreatic cancer is usually an adenocarcinoma and it usually arises from the pancreatic duct cells which make up the major part of the pancreas.

Kidney cancer or renal carcinoma usually occurs in older people and accounts for about 2 to 3% of cancers in adults, affecting about twice as many men as women. In adults, the most common type of kidney tumor is renal cell carcinoma, which begins in the cells that line the small tubes within your kidneys. Kidney cancer rarely strikes children and young adults; the exceptions are a pediatric kidney cancer called Wilms tumor and some forms of hereditary kidney cancer syndromes, such as von Hippel-Lindau disease.

Bladder cancer is a type of cancer that occurs in your bladder, a balloon-shaped organ in your pelvic area that stores urine. It is the fourth most common type of cancer in men and the eighth most common type in women. Tumors can develop on the surface of the bladder wall or in more severe cases, within the wall and into the underlying muscles. Cancer in the bladder typically affects older adults, though it can occur at any age.

Prostate is a glandular organ present only in males. It surrounds the neck of bladder & the first part of urethra and condributes a secretion to the semen. The gland is conical in shape and measures 3 cm in vertical diameter and 4 cm in transverse diameter.It has got five lobes anterior,posterior,two lateral and a median lobe.Since the first part of the urethra pass through it any lesion in the prostate will produce difficulty in passing urine.

Testicular cancer occurs most often in men between the ages of 20 and 39, and is the most common form of solid tumour in men between the ages of 15 and 34. It may also occur in young boys, but only about 3% of all testicular cancer is found in this group. Testicular cancer usually occurs in one testicle, however, 2-3% of tumors can occur in both testicles, either simultaneously or at a later date.

Colon cancer or colorectal cancer is one important cancer. In the western world, this cancer is considered as the third most common type of cancer and the second leading cause of death that are cancer-related.

Colon cancer causes 655,000 deaths every year. This type of cancer happens primarily on the person's colon, rectum and the appendix the moment cancerous growths appear on these areas.